Fda Said.the Fda

FDA Warns Taiwanese Drug Manufacturer Over GMP Violations

30-Jan-2013 By Zachary Brennan

As the Food and Drug Administration (FDA) ramps up its inspections of foreign pharma manufacturers in an attempt to root out GMP inconsistencies and faulty processes, a recent warning letter to Taiwanese manufacturer Beanne Chemical may serve as an example...

Pharmacy aseptic failings likely cause of vision loss; researchers

23-Jan-2012 By Nick Taylor

Poor aseptic technique at compounding pharmacies is the most likely cause of Avastin-related vision loss, researchers claim.

K-V prompts FDA investigation into compounding pharmacies

09-Nov-2011 By Nick Taylor

The FDA is investigating compounding pharmacies’ Makena after K-V Pharmaceutical said they differ from approved forms.

GSK hit with warning letter as FDA finds faults with UK site

19-Oct-2011 By Nick Taylor

The FDA has sent GSK a GMP warning letter after finding failings in steps to prevent microbiological contamination at a UK site.

Reformulation targeted in FDA unapproved drug plan

20-Sep-2011 By Nick Taylor

The FDA is targeting companies that reformulate drugs to evade enforcement as it tries to crackdown on the 1000s of products marketed without approval.